Ovarian cancer is the number one killer of women with gynecological cancers. One of the main reasons for this is ovarian cancer cells often become resistant to standard chemotherapyTreatment of cancer patients with anticancer drugs. Commonly called 'chemo'. These drugs work by attacking cell growth or division. Often these agents are used in combination to take advantage of their different modes of attack on cell division. treaments, which work by inducing cell death (apoptosisAlso called programmed cell death. Apoptosis is a natural process that occurs throughout the lives of almost all animals and plants. The death of the cells is a carefully controlled process that does not generate any inflammation.). A drug currently being studied for its anti-cancer effects may provide a new option for treating drug-resistant ovarian cancer. FTY720 induces cell death through a path entirely independent from the one triggered by current treatments. Thus, FTY720 offers the possibility of treating ovarian cancers even after they have become resistant to other apoptosis-inducing drugs.
Top